A Landrace Gene and a Patent Application
A start-up in Bhubaneswar sequences a traditional salt-tolerant rice landrace, 'Kala Jeera', conserved by farmers in the coastal saline belt of Odisha. The company identifies a promoter sequence that confers salt-inducible expression and files an Indian patent application on the isolated promoter and a transgenic rice containing it. The farmers' collective says the seed was shared with the company for a field trial under an oral agreement, with no written prior informed consent and no benefit-sharing terms. The company argues the promoter was isolated in the lab, the sequence was not known, and the landrace is publicly available. A state biodiversity official notes that the Biological Diversity Act, 2002 and the Nagoya Protocol apply. The company has spent ₹1.2 crore on research and has a pending collaboration with a public university. The patent examiner must decide whether to proceed, and the company must decide how to respond to the farmers.
1. Analyse the patentability issues and the access and benefit-sharing obligations raised by this application.
Read the worked answer
The promoter as an isolated nucleic acid may be novel and have industrial application, but patentability is not automatic. The examiner should ask whether the sequence is identical to a naturally occurring sequence and whether isolating it involved an inventive technical step. A claim to a transgenic rice plant is likely to face exclusion of plant varieties and essentially biological processes, although the isolated promoter claim may be examined separately. The source of the biological material must be disclosed.
Under the Biological Diversity Act, 2002, access to an Indian biological resource for research or commercial use requires prior approval from the National Biodiversity Authority, and Section 6 requires approval before applying for intellectual property rights. The oral agreement is not adequate prior informed consent and contains no mutually agreed terms. The fact that the landrace is publicly available does not remove benefit-sharing obligations. The farmers' collective is a benefit claimer, and Nagoya Protocol principles support written consent, disclosure of origin and fair benefit sharing. The examiner should not proceed to grant without clarification of these approvals; the company should regularise access and consent rather than argue that laboratory isolation alone extinguishes the farmers' rights.
2. Propose a benefit-sharing arrangement and a research path that could satisfy both the company and the farmers.
Read the worked answer
The company should negotiate a written prior informed consent and mutually agreed terms with the farmers' collective and the state biodiversity authority. A workable package could include an upfront access payment, milestone payments at patent grant and at first commercial sale, and a royalty on net sales of any salt-tolerant variety. Because the farmers conserved the landrace, non-monetary benefits matter: a community seed bank, local seed-production training, a share of planting material, and a trust fund for saline-land research. The company could grant the farmers a royalty-free licence to use the landrace and any improved non-transgenic lines for their own seed saving, while keeping commercial rights to the promoter construct. Publish the sequence and the field data so the public university can verify the work. The research path should include contained field trials, a biosafety review, and a clear plan for the transgenic rice before any release. This arrangement reduces legal risk and gives the company a defensible social licence.
3. What should the public university collaborator do before signing the collaboration agreement?
Read the worked answer
The university should carry out due diligence before signing. Ask for evidence of prior informed consent, National Biodiversity Authority approval and the material transfer agreement for the rice seed. Check whether the promoter sequence was derived from the landrace or from a laboratory construct, and whether the farmers' collective has agreed to the patent claims. The university should sign a collaboration agreement that sets out ownership of data and IP, publication rights, benefit-sharing obligations, and restrictions on transferring the rice material to third parties. It should not accept a clause that hides the source of the material or prevents disclosure. If transgenic field trials are planned, obtain institutional biosafety committee approval and follow containment rules. If the company cannot produce the access documents, the university should pause the collaboration rather than inherit a legal dispute.